|
|
Volumn 34, Issue 4, 2002, Pages 1252-1254
|
|
Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
a
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
HEPATITIS B HYPERIMMUNE GLOBULIN;
IMMUNOGLOBULIN;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ADULT;
ANTIGEN DETECTION;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DRUG MEGADOSE;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOPROPHYLAXIS;
KAPLAN MEIER METHOD;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RANK SUM TEST;
RECURRENT DISEASE;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
MORTALITY;
PASSIVE IMMUNIZATION;
PHYSIOLOGY;
PROSPECTIVE STUDY;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TIME;
ADULT;
COMPARATIVE STUDY;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HUMAN;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
LAMIVUDINE;
LIVER TRANSPLANTATION;
MALE;
PROSPECTIVE STUDIES;
RECURRENCE;
RETROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
SURVIVAL RATE;
TIME FACTORS;
HUMANS;
|
|
EID: 0035999044
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02637-4 Document Type: Article |
|
Times cited : (21)
|
|
References (9)
|
